Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
$153.23
+1.6%
$148.86
$135.34
$183.64
$334.23M0.729,203 shs8,288 shs
TMI
TriMetals Mining
C$0.00
C$0.03
C$0.12
C$43.69MN/A114,751 shs6,000 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
+1.62%+0.98%+4.72%-3.58%-11.16%
TMI
TriMetals Mining
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/AN/AN/AN/AN/AN/AN/A
TMI
TriMetals Mining
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
2.65
Moderate Buy$153.23N/A
TMI
TriMetals Mining
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/AN/AN/AN/AN/A
TMI
TriMetals Mining
N/AN/AN/A60.00C$0.10 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/A0.00N/AN/AN/AN/AN/A
TMI
TriMetals Mining
N/A-C$0.05N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
$1.250.82%N/AN/AN/A
TMI
TriMetals Mining
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/AN/A
TMI
TriMetals Mining
5.02
0.18
0.04

Institutional Ownership

CompanyInstitutional Ownership
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
32.05%
TMI
TriMetals Mining
N/A

Insider Ownership

CompanyInsider Ownership
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/A
TMI
TriMetals Mining
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/A2.22 millionN/AOptionable
TMI
TriMetals Mining
6364.09 millionN/ANot Optionable

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
VanEck Biotech ETF stock logo

VanEck Biotech ETF NASDAQ:BBH

$153.23 +2.44 (+1.62%)
Closing price 06/24/2025 03:59 PM Eastern
Extended Trading
$153.19 -0.04 (-0.03%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

TriMetals Mining TSE:TMI

TriMetals Mining Inc. engages in the acquisition, exploration, and development of mineral properties in Bolivia, Canada, Chile, and the United States. It primarily explores for gold, silver, and copper deposits. The company holds a 100% interest in the Gold Springs gold-silver project consisting of 961 unpatented lode claims, 13 patented lode claims, 5 Utah state mineral leases, and 1 surface real estate deed parcel covering a total of approximately 7,807 hectares, as well as an undivided interest in the 5 patented lode claims covering approximately 31.25 hectares located in Western Iron, Utah, and Eastern Lincoln Counties, Nevada. It also owns interest in the Escalones copper-gold porphyry project covering an area of 70 square kilometers located in the Chilean copper belt. The company was formerly known as South American Silver Corp. and changed its name to TriMetals Mining Inc. in March 2014. TriMetals Mining Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.